About the German market for biotechnology and pharmaceuticals
The German healthcare, biotechnology and pharamceuticals market is a continuous growing market with a worldwide influence and is seen as extremely influential and important for the country.
Since 2006, the gross value added within the healthcare industry has shown an average annual growth of 3.8%. Particularly in the case of exports, which amounted to a volume of around EUR 131.1 billion in 2018, an extraordinarily high average growth of 5.8% has been achieved for more than a decade. About one-third of the German medical technology industry's sales are generated with products that are less than three years old. In terms of patent applications, Germany also leads the field in Europe in 2018, with 26,734 out of nearly 175,000 patents.
With an increase of almost 10% compared to the previous year, the turnover of the total of 679 companies in the biotechnoloy sector increased to 4.51 billion euros in 2018. The German healthcare industry, as well as the biotechnology and pharmaceutical sectors, have enormous growth potential and innovative strength.
The Korean - German Health Congress
Get in touch with the German biotechnology and pharmceutical industry!
Participate in the Korean - German Health Congress. At the event, both industry experts and representatives of the German Embassy in Korea will give a presentation about the sector and the Korean-German business relationships. Furthermore, the German participating companies will present their companies and products.
Click here to learn more about the event and to register for the event free of charge.